Back to Journals » Infection and Drug Resistance » Volume 14
RETRACTED ARTICLE: Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome
Authors Liu F, Liu TT, Sun M 
, Zhou JM, Xue F, Chen SH, Chen J, Zhang L
Received 20 November 2020
Accepted for publication 19 February 2021
Published 3 March 2021 Volume 2021:14 Pages 859—867
DOI https://doi.org/10.2147/IDR.S292413
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Héctor Mora-Montes
This paper has been retracted.
Liu F, Liu TT, Sun M, et al. Infect Drug Resist. 2021;14:859–867.
We, the Editor and Publisher of Infection and Drug Resistance, have retracted the published article.
Following publication, concerns were raised by a third-party regarding the potential reuse of Figures 2G, 3E, 5F, and 5G across unrelated articles by different author groups. Further investigation by the publisher and journal has confirmed the integrity concerns of these images. When approached for an explanation, the authors did not respond to our queries. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore, retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted articles will remain online to maintain the scholarly record, but they will be digitally watermarked on each page as ‘Retracted’.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.